Berman Capital Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Berman Capital Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$0	Sell	219 -603	-73%	-$1.65K	﹤0.01%	2277
2021 Q2	$3K	Hold	822	–	–	﹤0.01%	1538
2021 Q1	$2K	Sell	822 -233	-22%	-$835	﹤0.01%	1567
2020 Q4	$3K	Hold	1,055	–	–	﹤0.01%	1350
2020 Q3	$4K	Hold	1,055	–	–	﹤0.01%	1150
2020 Q2	$3K	Buy	+1,055	New	+$3.07K	﹤0.01%	1200
2019 Q4	–	Sell	-86	Closed	-$695	–	1580
2019 Q3	$0	Hold	86	–	–	﹤0.01%	1621
2019 Q2	$0	Buy	+86	New	+$769	﹤0.01%	1614

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Berman Capital Advisors's SPPI Position: Q3 2021 in Review

Berman Capital Advisors reduced its Spectrum Pharmaceuticals Inc (SPPI) stake by 73% in Q3 2021, selling an estimated $1.65K and leaving 219 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Berman Capital Advisors first reported a position in SPPI in Q2 2019 and has held it in 8 quarters since. The position peaked at $4K in Q3 2020. 147 funds tracked by Wall St. Rank hold SPPI as of Q3 2021.

Berman Capital Advisors held 219 shares of Spectrum Pharmaceuticals Inc worth $0 as of Q3 2021.
Berman Capital Advisors sold 603 Spectrum Pharmaceuticals Inc shares in Q3 2021, an estimated $1.65K.
Spectrum Pharmaceuticals Inc made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #2277 holding.
Berman Capital Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q2 2019 and has held it in 8 quarters since.
Berman Capital Advisors's Spectrum Pharmaceuticals Inc position peaked at $4K in Q3 2020.
147 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.